Aurinia Pharmaceuticals (AUPH) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Aurinia Pharmaceuticals is intensifying its efforts to combat lupus nephritis (LN) during Lupus Awareness Month with a focus on education and advocacy. The company has launched a campaign to educate rheumatologists on the importance of early LN detection and kidney health, as well as supporting a Lupus Call to Action event featuring Grammy-winner Toni Braxton to promote health equity. These initiatives are part of Aurinia’s broader mission to improve outcomes and access for those affected by LN.
For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.